SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?


To: seminole who wrote (1488)3/11/2004 10:57:22 PM
From: Biomaven  Read Replies (1) | Respond to of 1826
 
Well I only got one taker for my Aloxi 2004 sales prediction contest - Ward, with a $150m prediction. To go with that, we have Merrill Lynch at $97.5m, which they say is street high, and mine at $140m.

Today's NCCN recommendation will certainly help move things along. Aloxi is plain and simply a better drug than its competitors, and it's great that this is now being "officially" recognized.

Peter